Literature DB >> 8213201

(R)-8-OH-DPAT preferentially increases dopamine release in rat medial prefrontal cortex.

L Arborelius1, G G Nomikos, U Hacksell, T H Svensson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8213201     DOI： 10.1111/j.1748-1716.1993.tb09584.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN： 0001-6772


× No keyword cloud information.
  15 in total

1.  Role of the medial prefrontal cortex in 5-HT1A receptor-induced inhibition of 5-HT neuronal activity in the rat.

Authors:  M Hajós; E Hajós-Korcsok; T Sharp
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

2.  The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions.

Authors:  Eleni T Tzavara; Richard J Davis; Kenneth W Perry; Xia Li; Craig Salhoff; Frank P Bymaster; Jeffrey M Witkin; George G Nomikos
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

3.  Intra-prefrontal 8-OH-DPAT and M100907 improve visuospatial attention and decrease impulsivity on the five-choice serial reaction time task in rats.

Authors:  Catharine A Winstanley; Yogita Chudasama; Jeffrey W Dalley; David E H Theobald; Jeffrey C Glennon; Trevor W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2003-04-02       Impact factor: 4.530

Review 4.  Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission.

Authors:  K D Alex; E A Pehek
Journal:  Pharmacol Ther       Date:  2006-10-17       Impact factor: 12.310

5.  Flibanserin, a drug intended for treatment of hypoactive sexual desire disorder in pre-menopausal women, affects spontaneous motor activity and brain neurochemistry in female rats.

Authors:  Boris Ferger; Makoto Shimasaki; Angelo Ceci; Carina Ittrich; Kelly A Allers; Bernd Sommer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-04-27       Impact factor: 3.000

6.  In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain.

Authors:  A Bortolozzi; L Díaz-Mataix; M Toth; P Celada; F Artigas
Journal:  Psychopharmacology (Berl)       Date:  2007-01-30       Impact factor: 4.530

7.  The 5-HT1A receptor antagonist (S)-UH-301 decreases dopamine release in the rat nucleus accumbens and striatum.

Authors:  G G Nomikos; L Arborelius; B B Höök; U Hacksell; T H Svensson
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

8.  Serotonin1B heteroreceptor activation induces an antidepressant-like effect in mice with an alteration of the serotonergic system.

Authors:  Franck Chenu; Denis J P David; Isabelle Leroux-Nicollet; Erwan Le Maître; Alain M Gardier; Michel Bourin
Journal:  J Psychiatry Neurosci       Date:  2008-11       Impact factor: 6.186

9.  Flibanserin, a potential antidepressant drug, lowers 5-HT and raises dopamine and noradrenaline in the rat prefrontal cortex dialysate: role of 5-HT(1A) receptors.

Authors:  Roberto William Invernizzi; Giuseppina Sacchetti; Stefania Parini; Sabrina Acconcia; Rosario Samanin
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

10.  5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion.

Authors:  Catharine A Winstanley; David E H Theobald; Jeffrey W Dalley; Jeffrey C Glennon; Trevor W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2004-06-30       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.